Brief: Polypeptide Group Says It Is Conducting Review Of Strategic Options
April 14 (Reuters) - POLYPEPTIDE GROUP AG PPGN.S: TAKES NOTE OF MARKET RUMORS AND SPECULATION AS A MATTER OF POLICY, POLYPEPTIDE DOES NOT COMMENT ON RUMORS AND SPECULATION CONDUCTING A REVIEW OF POTENTIAL STRATEGIC OPTIONS MARKET SPECULATION AND MEDIA REPORTS ACCORDING TO WHICH POLYPEPTIDE HAS ATTRACTED TAKEOVER INTEREST FROM CERTAIN INVESTORS Source text: ID:nEQ8bmfpma Further company coverage: PPGN.S (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com ; +48 587785269;;))
Recent news on PolyPeptide AG
See all newsBrief: Polypeptide Group Definitive Interim Result Of The Public Tender Offer Of Samsung Biologics
Brief: Polypeptide Group Provisional Interim Result Of The Public Tender Offer Of Samsung Biologics Co
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Samsung Biologics to launch takeover bid for PolyPeptide in September (updated)